2012 CABA Annual Conference: Meeting the Challenges Through Innovation 展望生物医药行业前景:以创新迎接挑战
Date: Saturday, April 7, 2012; 8:30 AM - 9:00 PM
Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA
Speakers and panelists include senior executives of US and Chinese bio/pharmaceutical companies, entrepreneurs, physicians, professors, and government officials
Themes/Topics
- Industry Trends and Key Technology Innovations
- Globalized R&D: Resourcing and Collaborations
- Career Development & Entrepreneurship
- Networking Receptions & Vendor Exhibitions
Confirmed Speakers
* Mark Bunnage, Ph.D., Pfizer - VP, Head of Chem. Bio. Research
* Detlev Biniszkiewicz, Ph.D., AstraZenaca - VP, IMED Strategy for Oncology
* Michael Foley, Ph.D., The Broad Institute - Director of Chemical biology
* Mark Namchuk, Ph.D., Vertex Pharmaceuticals - SVP, Research
* Ron Renaud, Idenix Pharmaceuticals - CEO
* Markus Warmuth, M.D., H3 Biomedicine - CEO
* Steve Hale, Ph.D., Ensemble Therapeutics - VP, Screening & Biochem
* Frank Feist, Ph.D., NobelGen - CEO
* Chen Chen, Ph.D., Sundia - CEO
* George Shi, Ph.D., Anichem - CSO
* Jifeng Liu, Ph.D., Aberiona - President
and more......
and more......
Admission: CABA members: FREE; Non-members: $20. Dinner reception: $30. Dinner pre-registration required. Limited tickets available. On-site and Online membership registration to CABA is available. ($20 annual membership fee for regular member, $10 for student)
For program update & online registration, please check CABA website: www.cabaweb.org
Please mark your calendar!
